Trade Mark Journal No.2026/020 15 May 2026
UK00004378280 24 April 2026 (5)

International priority date claimed: 16 January 2026
(United States of America)
(99599149)
- Class 5
- Medicated and pharmaceutical preparations for use in the treatment of fibromyalgia; prescription medicines for the treatment of fibromyalgia.
Axsome Therapeutics, Inc.
Representative: Keltie LLP